Evidence map›Paper›PMID 26342332›Full record

ArticleAtherosclerosis2015

Validity of self-report of lipid medication use: the Atherosclerosis Risk in Communities (ARIC) Study.

Sahiti Bhaskara, Eric A Whitsel, Christie M Ballantyne, Aaron R Folsom

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Atherosclerosis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sahiti BhaskaraDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 South Second Street, Suite 300, Minneapolis, MN 55454-1015, USA. Electronic address: bhask007@umn.edu.
Eric A WhitselCardiovascular Disease Program, Departments of Epidemiology and Medicine, University of North Carolina at Chapel Hill, Bank of America Center, Suite 301-B, 137 East Franklin Street, Chapel Hill, NC 27514, USA. Electronic address: eric_whitsel@unc.edu.
Christie M BallantyneDepartment of Medicine, Baylor College of Medicine, 6565 Fannin Street, Suite A656, MS A601, Houston, TX 77030, USA. Electronic address: cmb@bcm.tmc.edu.
Aaron R FolsomDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, 1300 South Second Street, Suite 300, Minneapolis, MN 55454-1015, USA. Electronic address: folso001@umn.edu.
Bank of America · USBaylor College of Medicine · US

Funding

NHLBI NIH HHS HHSN268201100005CNHLBI NIH HHS HHSN268201100005GNHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100006CNHLBI NIH HHS HHSN268201100007CNHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008CNHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009CNHLBI NIH HHS HHSN268201100009INHLBI NIH HHS HHSN268201100010CNHLBI NIH HHS HHSN268201100011CNHLBI NIH HHS HHSN268201100011INHLBI NIH HHS HHSN268201100012C
6 · The paper itself

Abstract

objectiveTo evaluate the validity of self-reported lipid medication use in an epidemiological study.

methodsWe studied medication self-reports compared with inventoried lipid medication containers at the fifth visit of the Atherosclerosis Risk in Communities (ARIC) Study in 2011-2013 (n = 6370). To assess the validity of self-reports, we computed sensitivity, specificity, positive and negative predictive values. We used multiple logistic regression to determine whether validity varied by participant characteristics. Comparisons were made with visit 4 (n = 11,531), to determine if there was a change in validity as the pattern and types of lipid medication used changed over time.

resultsThe prevalence of lipid medication use, according to medication containers was higher at visit 5 (56%) than visit 4 (14.3%). Statins were increasingly used. The percentage of participants reporting use/non-use accurately was 91.8% at visit 5, lower than visit 4 (97.3%). The unadjusted kappa coefficient of agreement was 0.83 (95% CI - 0.82 to 0.85) at visit 5 and 0.89 (95% CI - 0.88 to 0.90) at visit 4. Agreement was higher, compared with their counterparts, for women, younger and more educated participants, and those using fewer total medications.

conclusionIn this population sample, self-reported lipid medication use was highly accurate and therefore likely would be for similar epidemiological studies or clinical settings collecting this information.

Indexed as

AgedAged, 80 and overAtherosclerosisFemaleFollow-Up StudiesHumansHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsMaleMiddle AgedOdds RatioPredictive Value of TestsPrevalenceProspective StudiesReproducibility of ResultsSelf ReportHydroxymethylglutaryl-CoA Reductase InhibitorsLipidsLipid medicationMedication useStatinsValidation study

Identifiers

PMID26342332
PMCPMC4575898
OpenAlexW2108664801

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.